Article
Association of mammalian target of rapamycin with aggressive type II endometrial carcinomas and poor outcome: a potential target treatment.
Human pathology - 1 Feb 2013
Peiró Gloria, Peiró Francisca M, Ortiz-Martínez Fernando, Planelles María, Sánchez-Tejada Laura, Alenda Cristina, Ceballos Segundo, Sánchez-Payá José, Laforga Juan B
Abstract excerpt
The classification of endometrial carcinoma divided into types I and II has shown clinical usefulness. Molecular alterations of PTEN and Wnt/β-catenin have been identified in this neoplasia. However, the role of mammalian target of rapamycin according to subcellular localization in the pathogenesis of this neoplasia and its prognostic significance are not well defined. We studied the expression of phosphorylated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
